In this issue:
- Second COVID-19 wave conveys continuing uncertainty for vascular surgery, conclude speakers at ESVS Month (p. 1 and p. 4)
- “Starting to close the door on the paclitaxel controversy”: Late-breaking trials presented at TCT 2020 (p. 1 and p. 6)
- Profile: Chris Imray (p. 20)
- Overcoming challenges for a promising future: Rebecka Hultgren discusses aortic disease in men and women (p. 24)
